Biote Corp. Warrant
BTMDW
BTMDW was delisted on the 6th of July, 2023.
39 hedge funds and large institutions have $4.46M invested in Biote Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.
33% more capital invested
Capital invested by funds: $3.34M → $4.46M (+$1.12M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
9% less funds holding
Funds holding: 43 → 39 (-4)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$6.87M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$128K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$123K |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$67.9K |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$54.5K |
Top Sellers
BTMDW Hedge Fund Activity: Q4 2022 in Review
39 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biote Corp. Warrant (BTMDW) for Q4 2022, worth a combined $4.46M — up 33% from $3.34M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BTMDW and 3 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was BlueCrest Capital Management, adding an estimated $6.87M. The largest seller was Woodline Partners, exiting entirely with an estimated $102K sold.
- 39 institutional investors held Biote Corp. Warrant (BTMDW) as of Q4 2022, down from 43 in Q3 2022.
- Funds reported $4.46M of Biote Corp. Warrant stock for Q4 2022, up 33% quarter-over-quarter.
- 3 funds opened new Biote Corp. Warrant positions in Q4 2022 and 6 closed out, a net change of -3 holders.
- The largest Biote Corp. Warrant buyer in Q4 2022 was BlueCrest Capital Management, an estimated $6.87M added.
- The largest Biote Corp. Warrant seller in Q4 2022 was Woodline Partners, an estimated $102K sold.
Based on aggregated 13F filings for Q4 2022.